
Stay Ahead. Lead Change. Define Innovation.
What Makes AxioMed’s Disc Truly “Viscoelastic”?
- Anshul Jain
Founder’s Office, KIC Ventures

Spinal surgery is undergoing a much-needed transformation. Despite the volume of spinal fusions performed annually, studies show that only 75% of fusion or first-gen disc patients experience any clinical benefit. Worse still, 25% of these patients require reoperation within 10 years, and only a fraction return to work two years post-op.
That’s why AxioMed’s Freedom® Disc was built, to change that narrative.
At the heart of this innovation is a proprietary viscoelastic polymer designed to behave like a healthy human disc. Unlike traditional implants that use metal-on-poly components or mechanical hinges, the Freedom® Lumbar and Cervical Discs offer a single-piece, compressible core that:
· Responds to real-life spinal loading
· Moves in all three planes of motion
· Dampens shock, just like native disc tissue
A Human-Centric Design
The core's flexibility and stiffness were engineered to match the characteristics of real disc material. This is what sets AxioMed apart: a biomimetic disc that replicates the spine’s natural motion, not just substitutes it.
· 360° compression and rebound: Helps maintain stability under load
· 3D mobility: Allows flexion, extension, lateral bending, and axial rotation without stress points
· No articulating surfaces: Eliminates long-term wear, reduces implant debris
· Lab-tested to 50M+ cycles: Equivalent to 50 years of motion, even in younger, more active patients
Stability Through Science
The Freedom® Discs were not just built, they were proven. The product development involved top surgeons, polymer scientists, and biomechanical engineers working as a unified team. Results from extensive testing have shown that these implants not only withstand decades of use but function within the range of natural spine biomechanics.
This is what true viscoelasticity means: an implant that adapts to your body, not the other way around.
With FDA IDE trials underway, and a strong safety profile from global clinical use, AxioMed is preparing for U.S. market entry in 2025.
Designed for function. Engineered for longevity. Built for life.
Sources: 1. Cunningham BW, Gordon JD, Dmitriev AE, Hu N, McAfee PC. “Biomechanical Evaluation of Motion Segment Response to Total Disc Replacement Using a Viscoelastic Artificial Disc.” Spine Journal, 2010. 2. AxioMed LLC – Technology & Clinical Materials, 2025.